ABSTRACT
BACKGROUND This study aimed to determine the association of brain frailty with acute complications and prognosis in patients with acute ischemic stroke (AIS) due to occlusion of large vessels in the anterior circulation, and to further assess its predictive value.
METHODS AND RESULTS This multicenter, retrospective study included patients with AIS due to large vessel occlusion in the anterior circulation. All patients underwent MRI within seven days of stroke onset, measuring subcortical and cortical atrophy and leukoaraiosis as indicators of brain frailty.The study included 1,090 patients with a median age of 64 (interquartile range, 55–73) years and a median National Institutes of Health Stroke Scale (NIHSS) score of 9 (interquartile range, 4.5–15). Multivariable logistic regression analysis showed that independent risk factors for the unfavorable clinical outcome included: NIHSS score (OR, 1.17; 95% CI, 1.13–1.22), blood glucose (OR, 1.15; 95% CI, 1.04–1.26), infarct volume (OR, 1.32; 95% CI, 1.15–1.52), subcortical atrophy (OR, 1.27; 95% CI, 1.18–1.37), severe cortical atrophy (OR, 5.46; 95% CI, 1.71–17.45), and severe leukoaraiosis (OR, 4.68; 95% CI, 1.93–11.31). However, brain frailty was not significantly associated with AIS complications (malignant cerebral edema, parenchymal hemorrhage). Including brain atrophy indicators in the model significantly improved its unfavorable clinical outcome predictive power (AUC increased from 0.762 to 0.822; p < 0.001). The results remained stable in subgroup analyses across treatment modalities.
CONCLUSIONS Brain frailty was significantly associated with the unfavorable clinical outcome but not with acute complications. Brain frailty indicators contributed to the predictive efficacy, regardless of treatment modality.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded by the National Natural Scientific Foundation of China (82271983).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the local ethics committees of all participating institutions (2024DZKY-019-01). The requirement for informed consent was waived by the local ethics committees.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data that support the findings of this study are available on request from the corresponding author
Non-standard Abbreviations and Acronyms
- AIS
- acute ischemic stroke
- AUC
- area under the receiver operating characteristic curve
- CDFs
- cumulative distribution functions
- DWI
- diffusion-weighted imaging
- FLAIR
- fluid-enhanced inversion recovery
- mRS
- modified Rankin Scale
- NIHSS
- National Institutes of Health Stroke Scale
- ROC
- receptor operating characteristic
- T1WI
- T1-weighted imaging
- T2WI
- T2-weighted imaging
